March 14, 2024 | By Michelle Jones | Clinical Research, Clinical Trials, Liver, Liver Disease, Liver Health, NASH, News & Events
Today, we’re talking about some exciting news for people battling fatty liver disease, specifically Nonalcoholic Steatohepatitis (NASH) a condition where too much fat is stored in the liver, causing inflammation and damage. NASH is a tricky disease because it’s often …
July 22, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Clinical trials, Hepatitis in Children, Hepatitis Outbreak, Liver disease
The Sudden Wave of Hepatitis Amongst Children A recent upsurge in hepatitis cases involving children has caused alarm nationwide. Let’s dive into why this age group is suddenly experiencing a spike in occurrences. An Origin Story – How Cases of …
July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
June 8, 2022 | By John Raslavsky | Clinical Research, Hepatitis B | Blog, Clinical trials, liver health, Liver research
Like many other liver diseases, hepatitis B is a “silent epidemic” because most people do not have symptoms for most of the disease progression. It is one of the most common serious liver infections globally and in the state of …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …
May 11, 2022 | By John Raslavsky | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH
Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …
April 26, 2022 | By John Raslavsky | Clinical Research, Effects of Alcohol on the Liver, Fibroscan | AFLD, Blog, Clinical trials, Fatty Liver Disease, liver health
Alcohol is one of the most widely used substances among America’s adult and teen populations, posing substantial health and safety risks. Even though most know the adverse effects of alcohol, many tend to do so without fully recognizing the health …
March 30, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH
Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …
February 14, 2022 | By John Raslavsky | Clinical Research, Liver Health | American heart month, Blog, Clinical trials, heart-liver connection, Liver research
When we think of hearts, we think of Valentine’s Day and the exchange of cards and unique trinkets shared with our family and friends. February is also American Heart Month which creates awareness about heart disease, the number one cause …
December 14, 2021 | By John Raslavsky | Clinical Research, PCOS | Blog, Hepatic Clinical Trials, liver health, NAFLD, NASH
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition that encompasses excess fat accumulation, inflammation, and liver scarring, is on the rise. Multiple factors go into developing NAFLD, and it has been linked to several other conditions. Polycystic ovary …